Kyle Rose
Stock Analyst at Canaccord Genuity
(0.99)
# 3,576
Out of 4,827 analysts
114
Total ratings
28.57%
Success rate
-6.13%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNN Smith & Nephew | Maintains: Hold | $27 | $28.33 | -4.69% | 6 | Feb 26, 2025 | |
| PODD Insulet | Maintains: Buy | $304 → $324 | $257.00 | +26.07% | 16 | Feb 21, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $382.46 | +13.74% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $72.46 | -2.01% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $33.02 | +115.02% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.23 | +54.60% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.24 | +706.45% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $12.74 | +72.75% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $85.34 | +75.77% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $8.84 | +2,954.30% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $18.33 | +47.30% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.99 | +1,414.39% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $12.59 | +19.14% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $176.47 | -30.87% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $3.29 | +21.58% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.78 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $95.13 | +31.40% | 7 | Feb 8, 2022 |
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $28.33
Upside: -4.69%
Insulet
Feb 21, 2025
Maintains: Buy
Price Target: $304 → $324
Current: $257.00
Upside: +26.07%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $382.46
Upside: +13.74%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $72.46
Upside: -2.01%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $33.02
Upside: +115.02%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.23
Upside: +54.60%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.24
Upside: +706.45%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $12.74
Upside: +72.75%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $85.34
Upside: +75.77%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $8.84
Upside: +2,954.30%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $18.33
Upside: +47.30%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $0.99
Upside: +1,414.39%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $12.59
Upside: +19.14%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $176.47
Upside: -30.87%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $3.29
Upside: +21.58%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $6.78
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $95.13
Upside: +31.40%